INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 74 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $97,000 | -59.6% | 30,000 | -34.1% | 0.00% | -60.0% |
| Q1 2016 | $240,000 | -32.8% | 45,500 | 0.0% | 0.01% | -60.0% |
| Q4 2015 | $357,000 | -24.0% | 45,500 | -18.3% | 0.02% | +19.0% |
| Q3 2015 | $470,000 | +97.5% | 55,700 | +178.5% | 0.02% | +320.0% |
| Q1 2014 | $238,000 | -17.1% | 20,000 | -3.6% | 0.01% | -16.7% |
| Q4 2013 | $287,000 | -58.9% | 20,749 | -48.1% | 0.01% | -25.0% |
| Q3 2013 | $698,000 | +330.9% | 40,000 | +300.0% | 0.01% | +60.0% |
| Q2 2013 | $162,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
| AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
| BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
| GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
| Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
| Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
| Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
| DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
| KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |